NUBEQA
NDC 50419-395, darolutamide, tablet, film coated, from Bayer HealthCare Pharmaceuticals Inc..
- Product NDC
- 50419-395
- Status
- Listed
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212099
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50419-395 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAROLUTAMIDE300 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50419-395-01 | 50419039501 | 1 BOTTLE in 1 CARTON (50419-395-01) / 120 TABLET, FILM COATED in 1 BOTTLE |
| 50419-395-72 | 50419039572 | 1 BOTTLE in 1 CARTON (50419-395-72) / 120 TABLET, FILM COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1a7cb212-56e4-4b9d-a73d-bfee7fe4735e
Use it
Look up 50419-395 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50419-395 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50419-395. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.